Medicare Enrolled

Dr. Everardo Cobos, M.D.

Hematology & Oncology · Harlingen, TX
2902 HAINE DR, Harlingen, TX 78550
9562964000
Registered in NPPES since 2005
NPI: 1194713354 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cobos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cobos? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cobos

Dr. Everardo Cobos is a hematology & oncology specialist in Harlingen, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Cobos received a total of $1,960 from 29 pharmaceutical and/or device companies across 113 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cobos is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $1,960 industry payments

Industry Payment Transparency

Open Payments through 2023 ↗
$1,960
Total received (2018-2023)
Avg $327/year across 6 years
Bottom 40% in TX for hematology & oncology
29
Companies
113
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$291
2022
$488
2021
$379
2020
$132
2019
$317
2018
$351

Payments by company (2023)

Genentech USA, Inc.
$97
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$64
E.R. Squibb & Sons, L.L.C.
$35
Gilead Sciences, Inc.
$28
Mirati Therapeutics, Inc.
$21
AbbVie Inc.
$19
GENZYME CORPORATION
$16
PFIZER INC.
$13
Top 3 companies account for 67.1% of 2023 payments
All-time payments by company (2018-2023) ›
E.R. Squibb & Sons, L.L.C.
$337
PFIZER INC.
$257
Astellas Pharma US Inc
$239
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$224
Global Blood Therapeutics, Inc.
$134
Genentech USA, Inc.
$97
GENZYME CORPORATION
$71
Gilead Sciences, Inc.
$60
Allergan Inc.
$55
Janssen Pharmaceuticals, Inc
$54
MorphoSys, US Inc.
$42
Janssen Biotech, Inc.
$36
Otsuka America Pharmaceutical, Inc.
$35
Bayer HealthCare Pharmaceuticals Inc.
$33
EMD Serono, Inc.
$27
Karyopharm Therapeutics Inc.
$26
Regeneron Healthcare Solutions, Inc.
$23
Celgene Corporation
$23
ADC Therapeutics America, Inc.
$21
Mirati Therapeutics, Inc.
$21
Incyte Corporation
$21
AbbVie Inc.
$19
BeiGene USA, Inc.
$18
Janssen Scientific Affairs, LLC
$18
Epizyme, Inc.,
$16
Merck Sharp & Dohme Corporation
$15
Novartis Pharmaceuticals Corporation
$13
Lilly USA, LLC
$13
Blueprint Medicines Corporation
$12
Top 3 companies account for 42.5% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · AMBISOME · AVYCAZ · AYVAKIT · BRUKINSA · CAMZYOS · CHANTIX · CRESEMBA · Cresemba · DARZALEX · ELIQUIS · ELITEK · IBRANCE · IMBRUVICA · INLYTA · JYNARQUE · KEYTRUDA · KRAZATI · LIBTAYO · LifeVest · MONJUVI · OPDIVO · OXBRYTA · REBLOZYL · SARCLISA · Stivarga · TAZVERIK · TEFLARO · Trodelvy · XARELTO · XPOVIO · XTANDI · Xtandi
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Harlingen?
Compare hematology & oncology specialists in the Harlingen area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
4
County median income
$51,334
Nearest hospital to ZIP centroid (approximate)
VHS HARLINGEN HOSPITAL COMPANY LLC
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2023
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Cobos is a hematology & oncology specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Cobos receive payments from pharmaceutical companies?
Yes. Dr. Cobos received a total of $1,960 from 29 companies across 113 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Cobos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Hematology & Oncology Specialists in Harlingen
Browse hematology & oncology specialists in Harlingen ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →